Sartorius AG
XETRA:SRT
Intrinsic Value
Sartorius AG is a DE-based company operating in Health Care Equipment & Supplies industry. [ Read More ]
The intrinsic value of one SRT stock under the Base Case scenario is 244.98 EUR. Compared to the current market price of 212.5 EUR, Sartorius AG is Undervalued by 13%.
Valuation Backtest
Sartorius AG
Run backtest to discover the historical profit from buying and selling SRT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sartorius AG
Current Assets | 2B |
Cash & Short-Term Investments | 394.2m |
Receivables | 425.7m |
Other Current Assets | 1.1B |
Non-Current Assets | 7.8B |
Long-Term Investments | 114.8m |
PP&E | 2.1B |
Intangibles | 5.5B |
Other Non-Current Assets | 87.5m |
Current Liabilities | 1.3B |
Accounts Payable | 499.5m |
Accrued Liabilities | 92.3m |
Other Current Liabilities | 738.2m |
Non-Current Liabilities | 6.4B |
Long-Term Debt | 5B |
Other Non-Current Liabilities | 1.3B |
Earnings Waterfall
Sartorius AG
Revenue
|
3.4B
EUR
|
Cost of Revenue
|
-1.8B
EUR
|
Gross Profit
|
1.6B
EUR
|
Operating Expenses
|
-1B
EUR
|
Operating Income
|
543.3m
EUR
|
Other Expenses
|
-338.1m
EUR
|
Net Income
|
205.2m
EUR
|
Free Cash Flow Analysis
Sartorius AG
What is Free Cash Flow?
SRT Profitability Score
Profitability Due Diligence
Sartorius AG's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Sartorius AG's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
SRT Solvency Score
Solvency Due Diligence
Sartorius AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Score
Sartorius AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SRT Price Targets Summary
Sartorius AG
According to Wall Street analysts, the average 1-year price target for SRT is 372.3 EUR with a low forecast of 328.25 EUR and a high forecast of 435.75 EUR.
Shareholder Return
SRT Price
Sartorius AG
Average Annual Return | 31.46% |
Standard Deviation of Annual Returns | 54.86% |
Max Drawdown | -78% |
Market Capitalization | 14.5B EUR |
Shares Outstanding | 68 571 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sartorius AG is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 15,051 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.
Contact
IPO
Employees
Officers
The intrinsic value of one SRT stock under the Base Case scenario is 244.98 EUR.
Compared to the current market price of 212.5 EUR, Sartorius AG is Undervalued by 13%.